Last reviewed: May 26, 2026 Last updated: May 26, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
and Liu, Z
P.GholamiS.et al (2019)
Altered metabolites in the plasma of autism spectrum disorder: a capillary electrophoresis time-of-flight mass spectroscopy study
In addition to their unique effects, these peptides may differ in administration methods, such as subcutaneous injection, which require proper injection techniques for safety and effectiveness
But for someone dealing with both obesity and mild to moderate depressive symptoms, particularly when inflammation appears to be a contributing factor, a GLP-1 medication might provide benefits for both conditions simultaneously